May 27, 2021

Coverage of Ben Hsing’s Arrival at Venable

2 min

Ben Hsing’s arrival at Venable was covered by General Counsel News on May 27, 2021, Attorney at Law Magazine on May 28, and Citybiz New York on May 29.

Mr. Hsing is an accomplished trial lawyer with significant experience litigating patents across a broad range of technologies, including pharmaceutical compounds and formulations, telecommunication cables, treatment methods, genetically engineered seeds, medical devices, memory chips, light switches, imaging devices, and pet products. Mr. Hsing has secured favorable results for major pharmaceutical and technology companies in numerous high-profile cases. He regularly calls upon his experience as a patent examiner to provide comprehensive counsel to clients on matters before the U.S. Patent and Trademark Office (USPTO), including post-grant and contested patent office proceedings. He also conducts intellectual property (IP) due diligence investigations in connection with acquisitions and licensing deals. Mr. Hsing is deeply involved in his clients' matters, ensuring that he understands all aspects of their businesses and cases so that he can identify, dissect, and solve potential challenges facing his clients.

Commenting on his move to Venable, Mr. Hsing said, "Venable has become a major force among IP litigation firms, boasting a platform that can support my clients in the life sciences space as well as the broader range of industries in which I practice. I look forward to collaborating with many of my former colleagues as well as the other talented individuals at the firm."